Breast cancer screenings are being postponed during this COVID-19 crisis. So what does this mean for women who have concerns or are in the middle of treatment? Dr. Andrea Madrigrano from Rush University Medicine answers some of these questions.
Rush University’s Dr. Andrea Madgrigano speaks on the Empowered Patient Podcast about reducing her re-excision rate from 12% to 5% while utilizing the Kubtec MOZART 3D imaging specimen system.
During COVID-19 blood banks are reporting shortages. We encourage anyone who is willing & capable to give blood at your local donation center.
KUB Technologies, a U.S. medical device company that develops digital technologies used in the treatment of breast cancer, announced today it has been granted two new patents by the United States Patent and Trademark Office (USPTO).
The Connecticut Technology Council (CTC) and Marcum LLP announce the winners of the 2019 Marcum Tech Top 40, the 12th annual awards program from CTC and Marcum recognizing the fastest growing technology companies in Connecticut.
The Connecticut Technology Council (CTC) and Marcum LLP announced KUBTEC has made the Marcum Tech Top 40 (TT40) list of fastest growing technology companies in Connecticut.
